831
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Therapeutic Effects of SRT2104 on Lung Injury in Rats with Emphysema via Reduction of Type II Alveolar Epithelial Cell Senescence

, , , , , , , & show all
Pages 444-451 | Received 27 Feb 2020, Accepted 14 Jul 2020, Published online: 28 Jul 2020

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Seattle: GOLD; 2020. Available from: http://www.goldcopd.com/
  • Zheng H, Liu Y, Huang T, et al. Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke. Toxicol Lett. 2009;189(3):225–234. DOI:10.1016/j.toxlet.2009.06.850
  • Sundar IK, Rashid K, Gerloff J, et al. Genetic ablation of p16INK4a does not protect against cellular senescence in mouse models of chronic obstructive pulmonary disease/emphysema. Am J Respir Cell Mol Biol. 2018;59(2):189–199. DOI:10.1165/rcmb.2017-0390OC
  • Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med. 2010;61:105–119. DOI:10.1146/annurev.med.60.041807.123500
  • Hoffman AM, Ingenito EP. Alveolar epithelial stem and progenitor cells: emerging evidence for their role in lung regeneration. Curr Med Chem. 2012;19(35):6003–6008. DOI:10.2174/092986712804485872
  • Bordo D. Structure and evolution of human sirtuins. Curr Drug Targets. 2013;14(6):662–665. DOI:10.2174/1389450111314060007
  • Guarente L, Franklin H. Epstein lecture: Sirtuins, aging, and medicine. N Engl J Med. 2011;364(23):2235–2244. DOI:10.1056/NEJMra1100831
  • Salminen A, Kaarniranta K, Kauppinen A. Crosstalk between oxidative stress and SIRT1: impact on the aging process. Int J Mol Sci. 2013;14(2):3834–3859. DOI:10.3390/ijms14023834
  • Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460(7255):587–591. DOI:10.1038/nature08197
  • Satoh A, Stein L, Imai S. The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity. Handb Exp Pharmacol. 2011;206:125–162. DOI:10.1007/978-3-642-21631-2_7
  • Schultz MB, Rinaldi C, Lu Y, et al. Molecular and cellular characterization of SIRT1 allosteric activators. Methods Mol Biol. 2019;1983:133–149. DOI:10.1007/978-1-4939-9434-2_8
  • Guterres FA, Martinez GR, Rocha ME, et al. Simvastatin rises reactive oxygen species levels and induces senescence in human melanoma cells by activation of p53/p21 pathway. Exp Cell Res. 2013;319(19):2977–2988. DOI:10.1016/j.yexcr.2013.07.026
  • Hamsanathan S, Alder JK, Sellares J, et al. Cellular senescence: the Trojan horse in chronic lung diseases. Am J Respir Cell Mol Biol. 2019;61(1):21–30. DOI:10.1165/rcmb.2018-0410TR
  • Miyaji N, Nishida K, Tanaka T, et al. Inhibition of knee osteoarthritis progression in mice by administering SRT2014, an activator of silent information regulator 2 ortholog 1. Cartilage. 2020. DOI:10.1177/1947603519900795
  • Duan CM, Zhang JR, Wan TF, et al. SRT2104 attenuates chronic unpredictable mild stress-induced depressive-like behaviors and imbalance between microglial M1 and M2 phenotypes in the mice. Behav Brain Res. 2020;378:112296. DOI:10.1016/j.bbr.2019.112296
  • Zhang J, Bi R, Meng Q, et al. Catalpol alleviates adriamycin-induced nephropathy by activating the SIRT1 signalling pathway in vivo and in vitro. Br J Pharmacol. 2019;176(23):4558–4573. DOI:10.1111/bph.14822
  • Liu ZH, Zhang Y, Wang X, et al. SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition. Biomed Pharmacother. 2019;118:109227. DOI:10.1016/j.biopha.2019.109227
  • Wu H, Wu J, Zhou S, et al. SRT2104 attenuates diabetes-induced aortic endothelial dysfunction via inhibition of P53. J Endocrinol. 2018;237(1):1–14. DOI:10.1530/JOE-17-0672
  • Krueger JG, Suárez-Fariñas M, Cueto I, et al. A randomized, placebo-controlled study of SRT2104, a SIRT1 activator, in patients with moderate to severe psoriasis. PLoS One. 2015;10(11):e0142081. DOI:10.1371/journal.pone.0142081
  • van der Meer AJ, Scicluna BP, Moerland PD, et al. The selective Sirtuin 1 activator SRT2104 reduces endotoxin-induced cytokine release and coagulation activation in humans. Crit Care Med. 2015;43(6):e199–e202. DOI:10.1097/CCM.0000000000000949
  • Rabelo MAE, Lucinda LMF, Reboredo MM, et al. Acute lung injury in response to intratracheal instillation of lipopolysaccharide in an animal model of emphysema induced by elastase. Inflammation. 2018;41(1):174–182. DOI:10.1007/s10753-017-0675-5
  • Gu C, Li Y, Xu WL, et al. Sirtuin 1 activator SRT1720 protects against lung injury via reduction of type II alveolar epithelial cells apoptosis in emphysema. COPD. 2015;12(4):444–452. DOI:10.3109/15412555.2014.974740
  • Yao H, Chung S, Hwang JW, et al. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in nescence in mice. J Clin Invest. 2012;122(6):2032–2045. DOI:10.1172/JCI60132
  • Agarwal AR, Yin F, Cadenas E. Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. Am J Respir Cell Mol Biol. 2014;51(2):284–293. DOI:10.1165/rcmb.2013-0523OC
  • Li Y, Xu W, Yan J, et al. Differentiation of human amniotic fluid-derived mesenchymal stem cells into type II alveolar epithelial cells in vitro. Int J Mol Med. 2014;33(6):1507–1513. DOI:10.3892/ijmm.2014.1705
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408. DOI:10.1006/meth.2001.1262
  • Caito S, Rajendrasozhan S, Cook S, et al. SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 2010;24(9):3145–3159. DOI:10.1096/fj.09-151308
  • Martin TR. Recognition of bacterial endotoxin in the lungs. Am J Respir Cell Mol Biol. 2000;23(2):128–132. DOI:10.1165/ajrcmb.23.2.f189
  • Barnes PJ, Baker J, Donnelly LE. Cellular senescence as a mechanism and target in chronic lung diseases. Am J Respir Crit Care Med. 2019;200(5):556–564. DOI:10.1164/rccm.201810-1975TR
  • Barnes PJ. Pulmonary diseases and ageing. Subcell Biochem. 2019;91:45–74. DOI:10.1007/978-981-13-3681-2_3
  • Gu C, Li Y, Liu J, et al. LncRNA-mediated SIRT1/FoxO3a and SIRT1/p53 signaling pathways regulate type II alveolar epithelial cell senescence in patients with chronic obstructive pulmonary disease. Mol Med Rep. 2017;15(5):3129–3134. DOI:10.3892/mmr.2017.6367
  • Fujino N, Kubo H, Suzuki T, et al. Isolation of alveolar epithelial type II progenitor cells from adult human lungs. Lab Invest. 2011;91(3):363–378. DOI:10.1038/labinvest.2010.187
  • Conti V, Corbi G, Manzo V, et al. Sirtuin 1 and aging theory for chronic obstructive pulmonary disease. Anal Cell Pathol (Amst). 2015;2015:897327. DOI:10.1155/2015/897327
  • Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016;17(11):679–690. DOI:10.1038/nrm.2016.93
  • Baker JR, Vuppusetty C, Colley T, et al. MicroRNA-570 is a novel regulator of cellular senescence and inflammaging. FASEB J. 2019;33(2):1605–1616. DOI:10.1096/fj.201800965R
  • Ahmad T, Sundar IK, Tormos AM, et al. Shelterin telomere protection protein 1 reduction causes telomere attrition and cellular senescence via Sirtuin 1 deacetylase in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2017;56(1):38–49. DOI:10.1165/rcmb.2016-0198OC
  • Guillot L, Nathan N, Tabary O, et al. Alveolar epithelial cells: master regulators of lung homeostasis. Int J Biochem Cell Biol. 2013;45(11):2568–2573. DOI:10.1016/j.biocel.2013.08.009
  • Ganesan S, Unger BL, Comstock AT, et al. Aberrantly activated EGFR contributes to enhanced IL-8 expression in COPD airways epithelial cells via regulation of nuclear FoxO3A. Thorax. 2013;68(2):131–141. DOI:10.1136/thoraxjnl-2012-201719
  • Bargonetti J, Manfredi JJ. Multiple roles of the tumor suppressor p53. Curr Opin Oncol. 2002;14(1):86–91. DOI:10.1097/00001622-200201000-00015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.